were randomly assigned to exercise or non-exercise groups. Subjects in the experimental group exercised for 40 minutes three times per week for 15 weeks. The exercise consisted of combined arm and leg ergometry. Compared with baseline measures, the exercise group demonstrated significant increases in maximal oxygen consumption (VO 2 max) and upper-and lower-extremity strength, and significant decreases in skinfold, triglyceride, and very-low-density lipoprotein (VLDL) measurements. Depression and anger scores were also significantly reduced at weeks five and 10, and fatigue was reduced at week 10. Compared with the non-exercise subjects, exercise training resulted in improved fitness and had a positive impact on factors related to quality of life.
In 2004, White et al. 8 conducted a small study (n=8) examining progressive resistive exercise in people with MS. White reported a significant change (p<0.05) after the eight-week program in knee extension (7.4%), plantarflexion (52%), and stepping performance (8.7%). In addition, self-report by the subjects reflected a decrease in fatigue. This small study suggested that people with MS are capable of making positive adaptations to resistance training that may be associated with improved ambulation and decreased fatigue. Specific gait measures were not analyzed in the study by White et al.
U S N E U R O L O G Y
Another eight-week progressive resistance training program was conducted by Guiterrez in 2005. 9 In this specific study, the main outcome measures were kinematic gait parameters, including knee range of motion, duration of stance, swing, and double-support phases in seconds and percentage of time in each gait phase.
Isometric strength, three-minute stepping, fatigue, and self-reported disability were also measured. 
Occupational Therapy
One of the primary symptoms reported by individuals with MS is fatigue. 13 Cognitive impairment is another common symptom for people with MS.
A study by Gentry et al. 15 evaluated the effects of an occupational therapy training protocol using personal digital assistants (PDAs) as assistive technology to help with cognitive impairment related to MS.
Twenty participants were trained to use PDAs by an occupational therapist, and assessments of functional performance were taken at the start of an eight-week pre-treatment period and at the end of training.
The authors reported that the participants demonstrated the ability to learn how to use basic PDA functions and retain learning for at least eight weeks. In addition, functional performance increased significantly with PDA use, and this gain was maintained at eight-week follow-up.
Stretching Exercise and Baclofen (Lioresil) for Spasticity
Evidence supporting the use of therapeutic exercise focusing on stretching spastic muscles is inconclusive. 16 There is some positive evidence supporting the immediate effects of one stretching session;
however, it remains unclear how long these effects last and if there are any long-term consequences. 16 One study that does merit further research is that by Motl et al., 17 and clinical observation suggests that the beneficial effects of baclofen were noted when stretching exercises were added to the treatment.
Intravenous Methylprednisolone and Rehabilitation
Methylprednisolone administered intravenously (IVMP) is a common medical management in relapse of MS. 
Dalfampridine (Fampridine)
The dalfampridine extended-release tablet (AMPYRA™) is a new pharmaceutical agent that in laboratory studies has been found to improve impulse conduction in nerve fibers in which the insulating layer, or myelin, has been damaged. 19 Dalfampridine is a potassium channel 
Exercise and Brain-derived Neurotrophic Factor
One of the most exciting areas of investigation in the area of exercise and MS is the production of neurotrophins such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). 24 These neurotrophins are thought to play an important role in neuronal repair and plasticity, and recent experimental evidence suggests neuroprotective effects of these proteins in MS. 24 In a study conducted by Gold et al. in 2003, 24 basal NGF levels were significantly elevated in MS in response to acute exercise.
Thirty minutes of moderate exercise significantly induced BDNF production in people with MS and control subjects. The authors concluded that moderate exercise may be used to induce neutrophin production in humans.
In a study by White and Castellano, 25 11 individuals with MS and 11 age-matched controls completed an eight-week exercise program consisting of a three-minute warm-up at a self-assessed comfortable speed followed by 30 minutes of cycle ergometry at 60% of VO 2 max, three times per week. In this particular study, elevated resting serum BDNF was found following four weeks of exercise training, with a return to baseline at week eight in the MS group only. Similar observations have been reported in healthy animal models. At the end of the eightweek training period, BDNF levels in the subjects with MS had returned to baseline values. Exercise immunomodulation appears to be mediated by a complex interaction of hormones, cytokines, and neural factors that may favorably influence immune variables in MS and may have neuroprotective effects. 25 Further investigation is needed in this area.
Meta-analyses and Cochrane Reviews
Five reviews, meta-analyses, and Cochrane reviews have been 
